Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
Clinical trial NCT04398732 · COMPLETED
Trial details
- NCT number
- NCT04398732
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-05
- Primary completion
- 2020-10-01
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.